FIGURE 4.
MIF serum levels according to ‐173 G>C and ‐794 CATT5‐8 MIF polymorphisms in PP patients and CS. MIF serum levels according to MIF ‐173 G > C genotypes in plaque psoriasis (PP) patients (A) and CS (B). C and D show MIF serum levels according to different MIF ‐794 CATT5‐8 genotypes in PP patients and CS, respectively. p‐Values were calculated by the Kruskal–Wallis test, followed by Dunn's adjustment for multiple comparisons. The data are provided in medians and p25th–p75th. PP, Plaque psoriasis patients; CS, control subjects